Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11701330 Use of cannabinoids in the treatment of epilepsy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 10, 2021
0
Date of Patent
July 18, 2023
0
Patent Application Number
17472016
0
Patent Citations
‌
US Patent 11065209 Use of cannabidiol in the treatment of epilepsy
0
‌
US Patent 11311498 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11357741 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 11400055 Use of cannabidiol in the treatment of epilepsy
0
‌
US Patent 11406623 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
0
‌
US Patent 11426362 Oral cannabinoid formulations
0
‌
US Patent 11446258 Use of cannabinoids in the treatment of epilepsy
0
‌
US Patent 8293786 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
0
‌
US Patent 8673368 Cannabinoid-containing plant extracts as neuroprotective agents
0
‌
US Patent 9017737 Use of cannabinoids in combination with an anti-psychotic medicament
0
•••
Patent Citations Received
‌
US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
0
‌
US Patent 11963937 Use of cannabinoids in the treatment of epilepsy
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11701330
0
Patent Primary Examiner
‌
Matthew P Coughlin
0
CPC Code
‌
A61K 31/05
0

Find more entities like US Patent 11701330 Use of cannabinoids in the treatment of epilepsy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.